Decision Aid (DA) for Renal Patients

NYU Langone Health

Status: Enrolling

Conditions: Kidney Tumor; Renal Cancer

Treatments: Other: Institutional Pamphlet; Other: Decision Aid (DA) Web Tool

Study type: Interventional

Funder types: Other

Identifiers

NCT05387863

21-01670

Details and patient eligibility

About

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
• Patients scheduled for standard-of-care clinical exams with the NYU Urology Department

Exclusion criteria

• Stage IV cancer of any type
• Inability to provide informed consent
• Vulnerable subjects will not be recruited

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Decision Aid (DA) Web Tool

Experimental group

Treatment:

Other: Decision Aid (DA) Web Tool

Institutional Pamphlet

Active Comparator group

Treatment:

Other: Institutional Pamphlet